Direct Answer
No, Replikanto cannot be used with MatchTrader. Replikanto is designed to work exclusively with the NinjaTrader platform.
Why Replikanto Requires NinjaTrader
Replikanto is a NinjaTrader add-on, which means:
- FlowBots products, including Replikanto, are only compatible with NinjaTrader software
- To use Replikanto, you must connect your brokerage accounts through NinjaTrader
- Replikanto does not have a direct interface for connecting to brokers but rather uses accounts that are connected to NinjaTrader
Supported Brokers & Platforms
If you have accounts that are compatible with NinjaTrader software, they can be used with FlowBots products after being connected to NinjaTrader. Compatible brokers include:
- Rithmic
- Tradovate
- Interactive Brokers
- Other brokers supported by NinjaTrader
Note: MatchTrader is not currently supported as it cannot be connected to NinjaTrader.
System Requirements
- NinjaTrader must be installed on a Windows PC
- Replikanto is not compatible with MAC computers unless a virtual machine that emulates a Windows PC is used
- Standard NinjaTrader system requirements apply
How Broker Connections Work
To use Replikanto with your brokerage account:
- Connect your brokerage account to NinjaTrader first
- Ensure the connection is working properly in NinjaTrader
- Replikanto will then be able to interact with your connected account
It may be necessary to enable Multi-Provider Mode within NinjaTrader to connect more than one broker at the same time.
Alternative Platforms
If you're looking for trading automation solutions for other platforms (such as MetaTrader, cTrader, or MatchTrader), these are not compatible with Replikanto. Replikanto's functionality is specifically built for NinjaTrader's architecture and API.
Summary
Therefore, unless you can connect your MatchTrader account to NinjaTrader (which is currently not supported), you will not be able to use Replikanto with it. To use Replikanto, you need a brokerage account that can be connected to NinjaTrader and meets the system requirements.
Comments
0 comments
Article is closed for comments.